Serving New Jersey's
Diverse Population
I am thrilled to present our 2022-2023 Impact Report showcasing the community outreach and engagement efforts of the Cancer Health Equity Center of Excellence (CHECoE). This report highlights the profound impact we have had throughout New Jersey and beyond.
The CHECoE serves the entire state of New Jersey, striving to advance equitable access, enhance health care quality, reduce cancer health disparities, and improve outcomes across the cancer continuum from prevention, screening, and early detection through timely diagnosis, treatment, and survivorship. Through robust initiatives in research, education, training, community engagement, outreach, and public policy advocacy, we’re committed to creating lasting impact, fostering partnerships, and addressing the cancer burden within our communities.
In collaboration with our community partners and stakeholders, we have engaged, educated, screened, and helped navigate thousands of residents and families across New Jersey to health care. We’re also celebrating the launch of our mobile health unit LifeSaver. This state-of-the-art mobile health unit is equipped with two private screening rooms and a dedicated team of health professionals and care coordination staff. LifeSaver plays a crucial role in improving cancer awareness and access to health care by bringing essential cancer prevention, screening, education, and care directly to communities, particularly those facing disparities and high cancer burdens.
We are excited to share additional highlights including the continued development and enhancements of the Surveillance, Tracking and Reporting through Informed Data Collection and Engagement (STRIDE) dashboard. This interactive data and visualization dashboard was created by the CHECoE to bring together several publicly available sources into one central hub for community members, health care professionals and researchers to use. You’ll also learn about the expansion of the Community Science Cafés that promote meaningful dialogue between researchers and the community.
I extend my heartfelt thanks to our Community Cancer Action Board members whose invaluable insights and leadership contribute immensely to our mission. I am deeply grateful to our dedicated community partners, staff, and faculty. It is an honor and privilege to collaborate with you as we engage meaningfully with every corner of the state, working together to reduce New Jersey’s cancer burden and build a healthier and more equitable future.
Anita Y. Kinney, PhD, RN, FAAN, FABMR
Director, Cancer Health Equity Center of Excellence,
Rutgers Cancer Institute;
Director, ScreenNJ
